IDTA Share Price Performance
US$0.16
-0.40 (-71.43%)
Price US$0.16
Share PriceUS$0.16
IDenta Corp. Stock Price
- 0 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
IDTA Community Narratives
There are no narratives available yet.
Recent IDTA News & Updates
IDenta Corp. Key Details
Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
- Earnings per share (EPS)
- -0.011
- Gross Margin
- 44.14%
- Net Profit Margin
- -3.71%
- Debt/Equity Ratio
- 59.9%
IDenta Corp. Competitors
Snowflake Analysis
About IDTA
- Founded
- 2002
- Employees
- 14
- CEO
- WebsiteView website
IDenta Corp. operates as a detection and forensic science company. The company offers drug testing kits, explosives testing kits, aero chamber sniffer, forensic, urine drug testing, and saliva drug testing products. It provides its solutions to law enforcement, military, and government agencies, as well as other organizations that deal in fighting illicit drugs and terrorist threats. The company has operations in Israel, the United States, the United Nations, DEA, Germany, France, Italy, Spain, Indonesia, Brazil, Mexico, South Africa, Nigeria, Canada, and internationally. IDenta Corp. was founded in 2002 and is headquartered in Jerusalem, Israel.
Market Insight
Q4 2025 is off to a flying start with record highs being printed left, right, and center. US and Japanese stocks made fresh new highs, while the gold price powered through $4,000 for the first time, and Bitcoin crossed the $126k level. Is this all a case of USD weakness, irrational exuberance, or solid fundamentals? This week, we are reviewing Q3 market performance, Q2 earnings season, and the outlook heading into the end of 2025…
Continue reading
Israeli Market Performance
- 7 Days: 2.8%
- 3 Months: 6.0%
- 1 Year: 61.7%
- Year to Date: 35.8%
The market has climbed by 2.8% over the past week, with every sector up and the Real Estate sector leading the way. As for the past 12 months, the market is up 63%. Looking forward, earnings are forecast to grow by 16% annually. Market details ›